Undesirable Effects After Treatment With Dermal Fillers

April 2013 | Volume 12 | Issue 4 | Original Article | E59 | Copyright © 2013

Ana Rita Rodrigues-Barata MD and Francisco M. Camacho-Martínez MD

Department of Medical-Surgical Dermatology, Hospital Clínico Virgen Macarena School of Medicina, University of Seville, Seville, Spain

Abstract

BACKGROUND: Soft tissue augmentation is one of the most frequent techniques in cosmetic dermatology. Nowadays, there are a high number of available materials. Nonanimal hyaluronic acid (HA) is one of most useful fillers for lip augmentation and for treating nasolabial folds, marionette lines, and the dynamic wrinkles of the upper face.
OBJECTIVE: To evaluate the type and management of undesirable effects of nonanimal reticulated or stabilized HA observed in our cosmetic unit in the past 3 years.
MATERIALS and METHODS: The consecutive patients using HA attending to our clinic in the past 3 years were divided into 3 categories, according to the time of presentation of the adverse reactions: immediate, early, and late-onset complications. All patients were treated.
RESULTS: Twenty-three patients presented to our clinic complaining of complications after soft tissue augmentation with HA. Ten patients presented immediate-onset complications, 8 showed early-onset complications, and 5 cases complaint of late-onset complications. Treatment of the first group consisted of hyaluronidase injection, massage, and topical antibiotics. Early- and late-onset complications were treated with intralesional triamcinolone acetonide. All patients improved, with the exception of a woman with recurrent granulomas.
CONCLUSION: Generally, undesirable effects of HA (immediate, early, or late onset) are not frequent, and when present, they improve if treated properly. Physicians need to be aware of these possible adverse events in order to establish proper treatment and prevent scarring or other sequelae.

J Drugs Dermatol. 2013;12(4):e59-e62.

Purchase Original Article

Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.

Download the original manuscript as it was published in the JDD.

Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.

To get access to JDD's full-text articles and archives, upgrade here.

Save an unformatted copy of this article for on-screen viewing.

Print the full-text of article as it appears on the JDD site.

→ proceed | ↑ close

INTRODUCTION

Dermal fillers have been used to improve the loss of facial volume for more than 20 years, although with the new products, this cosmetic procedure has undergone significant development in recent years, especially when used for lip augmentation1 or to restore volume of nasolabial folds, marionette lines, and dynamic wrinkles of the upper face.2 Presently, it is considered the second most popular medical cosmetic procedure in the United States.3 Although the techniques and materials are relatively safe, the number of undesirable effects reported has increased each year.

Permanent fillers are responsible for most of the reported side effects, while resorbable materials are safer. In our experience, the best resorbable material for soft tissue implantation is hyaluronic acid (HA) of nonanimal origin with a medium density (HAMD), which can be present with a high or low grade of reticulation, the last known as nonanimal stabilized HA (NASHA).4 A recent comparative study conducted by Brandt et al5 found that both small and large gel-particle HA are safe and effective in facial rejuvenation, but a new HA-based dermal filler Uma Jeunesse that uses a new cross-linking technology was shown to be safer and to have a higher longevity in skin tissue than Juvéderm.6 HA filler longevity seems to be related to the different resistance to hyaluronidase and/or free radical degradation in the different products, according to their physical properties,7 and the knowledge of this characteristics allows physicians to choose the appropriate product for each patient according to their expectations and needs.8 The adverse events (AEs) can be classified according to their onset time. Immediate-onset reactions appear in the first 24 to 48 hours after the filler injection and include vascular obstruction, reactions associated with the injection technique (erythema, edema, hematoma, pain, or tenderness),9 hypersensitivity reactions, and skin discoloration. Early-onset AEs appear within 14 days after injection and usually consist of transient reactions and infections. Late-onset complications develop more than 14 days after the injection and can present in the form of delayed hypersensitivity, product migration, nodules, and granulomas.10-12 The majority of AEs are related to inadequate injection technique, mostly at an inappropriate depth. The best level for HAMD injection is the mid or deep dermis; collagen should be injected into the reticular dermis, calcium hydroxyapatite and tricalcium phosphate in the transition between the dermis and subcutaneous tissue, and fat and polylactic acid in the subcutaneous tissue.

In this situation, we decided to evaluate the complications of soft tissue augmentation with nonanimal reticulated or stabilized HA observed in our cosmetic unit in the past 3 years.

MATERIAL AND METHODS

We reviewed consecutive patients who presented to our cosmetic unit in the past 3 years complaining about AEs associated with absorbable fillers for soft tissue augmentation, concretely HA. All patients received the filler injection outside our clinic.

↑ back to top


Related Articles